Pier Capital’s bluebird bio BLUE Stock Holding History

Pier Capital’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,012	Closed	-$2.64M	–	118
2016 Q3	$2.64M	Buy	+3,012	New	+$2.18M	0.47%	101

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Pier Capital's BLUE Position: Q4 2016 in Review

Pier Capital sold out of bluebird bio (BLUE) in Q4 2016, closing a stake of 3,012 shares — an estimated $2.64M sold.

Pier Capital first reported a position in BLUE in Q3 2016 and held it in 1 quarter. The position peaked at $2.64M in Q3 2016. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

Pier Capital reported no remaining bluebird bio position as of Q4 2016 after selling out during the quarter.
Pier Capital sold 3,012 bluebird bio shares in Q4 2016, an estimated $2.64M.
Pier Capital first reported a position in bluebird bio in Q3 2016 and held it in 1 quarter.
Pier Capital's bluebird bio position peaked at $2.64M in Q3 2016.
199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on Pier Capital's 13F filing for Q4 2016, filed 14 Feb 2017.